Clinical management of protein C deficiency

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 3, 2001, Pages 431-439

  Pescatore, S L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Heterozygous; Homozygous; Oral anticoagulation; Protein C concentrate; Protein C deficiency treatment

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; COUMARIN; COUMARIN DERIVATIVE; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMA PROTEIN; PROTEIN C; PROTHROMBIN; PROTHROMBIN COMPLEX; STEROID; THROMBIN; THROMBOMODULIN; VITAMIN K GROUP; WARFARIN;

BLOOD CLOT; CAPILLARY ENDOTHELIUM; CELL SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG RESPONSE; ENDOTHELIUM CELL; FATALITY; FULMINATING PURPURA; GENETIC DISORDER; HEMOSTASIS; HEPARINIZATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIVER TRANSPLANTATION; LUNG EMBOLISM; MICROCIRCULATION; NEWBORN; NEWBORN PERIOD; PATIENT; PROTEIN C DEFICIENCY; REVIEW; SKIN NECROSIS; SYMPTOM; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PROTEIN C DEFICIENCY;

EID: 0035025023     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.3.431     Document Type: Review

References (33)

1. Hereditary protein C deficiency: A review of the genetics, clinical presentation, diagnosis and treatment
2. Advances in the etiology and treatment of venous thromboembolism
3. Clinical relevance of protein C
4. Diagnosis and treatment of homozygous protein C deficiency
5. Protein C and S deficiency
6. The hypercoagulable state
7. Treatment of homozygous protein C deficiency with subcutaneous protein C concentrate
8. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis
9. Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg-1 to His
10. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency
11. Homozygous protein C deficiency in two siblings
12. Homozygous protein C deficiency: Description of a new and successful treatment with low molecular weight heparin
13. Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months
14. Dysfunctional protein C deficiency (Type II)
15. Homozygous protein C deficiency: Early treatment with warfarin
16. Purpura fulminans in severe congenital protein C deficiency: Monitoring of treatment with protein C concentrate
17. Long-term management of homozygous protein C deficiency: Replacement therapy with subcutaneous purified protein C concentrate
18. Heparin induced thrombocytopenia
19. Thrombotic microangiopathy in three patients with cured lymphoma
20. Heparin induced thrombocytopenia: A ten year retrospective
21. Thrombophilia: Disorders predisposing to venous thromboembolism
22. Thrombotic disease
23. Management of patients with hereditary hypercoagulable disorders
24. Hypercoagulable states
25. Protein C concentrate in the treatment of warfarin induced skin necrosis
26. Activated protein C concentrate: A new tool for the treatment of acute thromboembolism in patients with congenital protein C deficiency
27. Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, Factor VII, Factor X, protein C, protein S, or protein Z
28. Type-I protein C deficiency caused by disruption of a hepatocyte nuclear factor (HNF)-6/HNF-1 binding sit in the human protein C gene promoter
29. Infectious purpura fulminans: Diagnosis and treatment
30. Protein C deficiency and venous thrombosis - The search for the second genetic defect
31. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans
32. Homozygous protein C deficiency: Description of a new mutation and successful treatment with low molecular weight heparin
33. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate